-
srdr.ahrq.gov/projects/1520/studies/186825
January 01, 2015 - • Do the benefits and harms vary by patient characteristics, course of illness, or other factors?
-
srdr.ahrq.gov/projects/1520/studies/186824
January 01, 2013 - • Do the benefits and harms vary by patient characteristics, course of illness, or other factors?
-
srdr.ahrq.gov/projects/1520/studies/197240
January 01, 2020 - Do the (comparative) effects and harms vary by patient characteristics, course of illness, or other factors
-
srdr.ahrq.gov/projects/1520/studies/186810
January 01, 2019 - Do the (comparative) effects and harms vary by patient characteristics, course of illness, or other factors
-
srdr.ahrq.gov/projects/1520/studies/186763
January 01, 2019 - Do the (comparative) effects and harms vary by patient characteristics, course of illness, or other factors
-
srdr.ahrq.gov/projects/1565/studies/189572
January 01, 2013 - Exclusion criteria
patients with other additional risk factors
-
srdr.ahrq.gov/projects/1312/studies/133275
January 01, 2013 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors
-
srdr.ahrq.gov/projects/1312/studies/182267
January 01, 2018 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors
-
srdr.ahrq.gov/projects/1520/studies/186845
January 01, 2014 - Do the (comparative) effects and harms vary by patient characteristics, course of illness, or other factors
-
srdr.ahrq.gov/projects/1520/studies/186755
January 01, 2015 - Do the (comparative) effects and harms vary by patient characteristics, course of illness, or other factors
-
srdr.ahrq.gov/projects/1520/studies/186756
January 01, 2002 - Do the (comparative) effects and harms vary by patient characteristics, course of illness, or other factors
-
srdr.ahrq.gov/projects/1520/studies/186817
January 01, 2007 - Do the (comparative) effects and harms vary by patient characteristics, course of illness, or other factors
-
srdr.ahrq.gov/projects/1520/studies/186841
January 01, 2014 - • Do the benefits and harms vary by patient characteristics, course of illness, or other factors?
-
srdr.ahrq.gov/projects/1312/studies/133109
January 01, 2011 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk factors
-
srdr.ahrq.gov/projects/1520/studies/186761
January 01, 2017 - Do the (comparative) effects and harms vary by patient characteristics, course of illness, or other factors
-
srdr.ahrq.gov/projects/1520/studies/186797
January 15, 2021 - Do the (comparative) effects and harms vary by patient characteristics, course of illness, or other factors
-
srdr.ahrq.gov/projects/1520/studies/186727
December 01, 2013 - Do the (comparative) effects and harms vary by patient characteristics, course of illness, or other factors
-
srdr.ahrq.gov/projects/1520/studies/186816
January 01, 2002 - Do the (comparative) effects and harms vary by patient characteristics, course of illness, or other factors
-
srdr.ahrq.gov/projects/1520/studies/186726
February 01, 2007 - Do the (comparative) effects and harms vary by patient characteristics, course of illness, or other factors
-
srdr.ahrq.gov/projects/1520/studies/186224
January 01, 2019 - Do the (comparative) effects and harms vary by patient characteristics, course of illness, or other factors